US5418154A
(en)
*
|
1987-11-17 |
1995-05-23 |
Brown University Research Foundation |
Method of preparing elongated seamless capsules containing biological material
|
US5871472A
(en)
*
|
1987-11-17 |
1999-02-16 |
Brown University Research Foundation |
Planting devices for the focal release of neuroinhibitory compounds
|
US5283187A
(en)
*
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
US5487739A
(en)
*
|
1987-11-17 |
1996-01-30 |
Brown University Research Foundation |
Implantable therapy systems and methods
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
US5529914A
(en)
*
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
GB9025372D0
(en)
*
|
1990-11-22 |
1991-01-09 |
Nat Res Dev |
Pharmaceutical dosage forms
|
EP0585368B1
(de)
*
|
1991-04-25 |
1997-08-06 |
Brown University Research Foundation |
Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
|
US5800829A
(en)
*
|
1991-04-25 |
1998-09-01 |
Brown University Research Foundation |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
|
US6503277B2
(en)
*
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
US20040175795A1
(en)
*
|
1991-09-20 |
2004-09-09 |
Amgen Inc. |
Glial derived neurotrophic factor
|
CA2119463C
(en)
|
1991-09-20 |
2003-09-16 |
Leu-Fen H. Lin |
Glial cell line-derived neutrophic factor
|
EP0610441A4
(de)
*
|
1991-10-29 |
1996-01-10 |
Clover Cons Ltd |
Vernetzbare polysacchariden, polykationen und lipiden verwendbar zum einkapseln und abgabe von arzneimitteln.
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
DK0627911T3
(da)
*
|
1992-02-28 |
2000-11-20 |
Univ Texas |
Fotopolymeriserbare bionedbrydelige hydrogeler somvævskontaktmaterialer og bærere med reguleret frigivelse
|
CA2140905A1
(en)
*
|
1992-07-29 |
1994-01-30 |
Keith E. Dionne |
Use of pouch of implantation of living cells
|
US5245896A
(en)
*
|
1992-08-19 |
1993-09-21 |
Kennametal Inc. |
Quick-change tool holder with center height adjustment mechanism
|
US5871985A
(en)
*
|
1992-09-28 |
1999-02-16 |
Brown University Research Foundation |
Particulate non cross-linked chitosan core matrices for encapsulated cells
|
WO1994007999A1
(en)
*
|
1992-09-28 |
1994-04-14 |
Brown University Research Foundation |
Chitosan matrices for encapsulated cells
|
FR2696658B1
(fr)
*
|
1992-10-14 |
1994-11-18 |
Hospal Ind |
Procédé et dispositif d'encapsulation d'une substance, ainsi que capsule obtenue.
|
JPH08510274A
(ja)
*
|
1993-04-27 |
1996-10-29 |
サイトセラピュティックス インコーポレイテッド |
アクリロニトリルベースのポリマーにより形成された膜
|
AU688776B2
(en)
*
|
1993-06-23 |
1998-03-19 |
Brown University Research Foundation |
Method and apparatus for sealing implantable, membrane encapsulation devices
|
DE938893T1
(de)
*
|
1993-08-10 |
2000-03-09 |
Gore & Ass |
Zelleinkapselungsvorrichtung
|
CA2169292C
(en)
*
|
1993-08-12 |
2010-11-23 |
E. Edward Baetge |
Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5908623A
(en)
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5620883A
(en)
*
|
1994-04-01 |
1997-04-15 |
The Johns Hopkins University |
Living cells microencapsulated in a polymeric membrane having two layers
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US5935849A
(en)
*
|
1994-07-20 |
1999-08-10 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
US5834029A
(en)
*
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
|
US5776747A
(en)
*
|
1994-07-20 |
1998-07-07 |
Cytotherapeutics, Inc. |
Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
|
US6495364B2
(en)
*
|
1995-05-23 |
2002-12-17 |
Neurotech, S.A. |
Mx-1 conditionally immortalized cells
|
US5681740A
(en)
*
|
1995-06-05 |
1997-10-28 |
Cytotherapeutics, Inc. |
Apparatus and method for storage and transporation of bioartificial organs
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
US5837234A
(en)
*
|
1995-06-07 |
1998-11-17 |
Cytotherapeutics, Inc. |
Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
|
WO1997010807A1
(en)
*
|
1995-09-22 |
1997-03-27 |
Gore Hybrid Technologies, Inc. |
Improved cell encapsulation device
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
US6184200B1
(en)
|
1995-09-28 |
2001-02-06 |
Amgen Inc. |
Truncated glial cell line-derived neurotrophic factor
|
US5855613A
(en)
*
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
DE19539361A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
US5641749A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
US5641750A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US6087129A
(en)
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
US6110707A
(en)
*
|
1996-01-19 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Recombinant expression of proteins from secretory cell lines
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
CA2252665A1
(en)
*
|
1996-05-21 |
1997-11-27 |
Patrick Aebischer |
System and method for delivery of cytokines using encapsulated cytokine-secreting cells
|
US6054142A
(en)
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
FR2753086B1
(fr)
*
|
1996-09-12 |
1999-02-26 |
Hospal R & D Int |
Dispositif et procede de fabrication d'une capsule tubulaire segmentee contenant un milieu biologiquement actif
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
US6306491B1
(en)
|
1996-12-20 |
2001-10-23 |
Gore Enterprise Holdings, Inc. |
Respiratory aids
|
FR2766088B1
(fr)
*
|
1997-07-17 |
2001-01-05 |
Dow Corning Sa |
Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
|
US6347930B1
(en)
*
|
1997-09-11 |
2002-02-19 |
Hospal R & D Int. |
Device and method for manufacturing a segmented tubular capsule containing a biologically active medium
|
US6303136B1
(en)
|
1998-04-13 |
2001-10-16 |
Neurotech S.A. |
Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
US6322962B1
(en)
|
1998-08-14 |
2001-11-27 |
Board Of Regents, The University Of Texas System |
Sterol-regulated Site-1 protease and assays of modulators thereof
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
US7708993B2
(en)
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
SI1149114T1
(sl)
|
1999-02-03 |
2014-08-29 |
Amgen Inc. |
Polipeptidi, vkljuäśeni v imunskem odgovoru
|
ES2353728T3
(es)
|
1999-02-10 |
2011-03-04 |
Curis, Inc. |
Péptido yy (pyy) para tratar trastornos metabólicos de la glucosa.
|
US7745216B2
(en)
|
1999-02-10 |
2010-06-29 |
Curis, Inc. |
Methods and reagents for treating glucose metabolic disorders
|
US6365385B1
(en)
|
1999-03-22 |
2002-04-02 |
Duke University |
Methods of culturing and encapsulating pancreatic islet cells
|
US6303355B1
(en)
|
1999-03-22 |
2001-10-16 |
Duke University |
Method of culturing, cryopreserving and encapsulating pancreatic islet cells
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
AU781265B2
(en)
*
|
1999-09-30 |
2005-05-12 |
Unisearch Limited |
Method and apparatus for culturing cells
|
AUPQ319199A0
(en)
*
|
1999-09-30 |
1999-10-28 |
Unisearch Limited |
Method and apparatus for culturing cells
|
US6878543B1
(en)
|
1999-10-25 |
2005-04-12 |
Nsgene Sa |
Cultures of GFAP+ nestin+ cells that differentiate to neurons
|
US6365171B1
(en)
|
1999-11-04 |
2002-04-02 |
The University Of Akron |
Amphiphilic networks, implantable immunoisolatory devices and methods of preparation
|
US7635390B1
(en)
|
2000-01-14 |
2009-12-22 |
Marctec, Llc |
Joint replacement component having a modular articulating surface
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
FI111057B
(fi)
*
|
2000-05-29 |
2003-05-30 |
Conenor Oy |
Ekstruusiomenetelmä ja ekstruusiolaite
|
EP1294879B1
(de)
|
2000-06-28 |
2008-12-31 |
Amgen Inc. |
Thymus-stroma lymphopoietin rezeptor-moleküle und deren verwendung
|
AU1796902A
(en)
|
2000-11-28 |
2002-06-11 |
Amgen Inc |
Novel polypeptides involved in immune response
|
DE60140693D1
(en)
|
2000-12-14 |
2010-01-14 |
Amylin Pharmaceuticals Inc |
Ankheiten
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
EP1639972B1
(de)
|
2001-08-01 |
2013-09-11 |
Anecova SA |
Intrauterine Vorrichtung
|
AU2002324278B2
(en)
*
|
2001-08-01 |
2006-08-17 |
Anecova Sa |
Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
|
DE10164039A1
(de)
*
|
2001-12-28 |
2003-07-10 |
Nmi Univ Tuebingen |
Implantierbare Vorrichtung und deren Verwendung
|
US7662924B2
(en)
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
BRPI0311182A2
(pt)
*
|
2002-05-16 |
2016-06-21 |
Absorber Ab |
método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
ES2328640T3
(es)
|
2003-04-18 |
2009-11-16 |
Biogen Idec Ma Inc. |
Neublastina conjugada con un polimero glicosilada.
|
WO2004108760A2
(en)
|
2003-06-10 |
2004-12-16 |
Nsgene A/S |
Improved secretion of neublastin
|
US8501473B2
(en)
|
2003-07-16 |
2013-08-06 |
Evotec International Gmbh |
Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
|
WO2005033297A1
(en)
*
|
2003-09-19 |
2005-04-14 |
The Rockefeller University |
Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
|
BRPI0415563A
(pt)
|
2003-10-20 |
2007-01-02 |
Nsgene As |
método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional
|
ATE409741T1
(de)
*
|
2004-01-19 |
2008-10-15 |
Nsgene As |
Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen
|
US8603969B2
(en)
|
2004-02-11 |
2013-12-10 |
Amylin Pharmaceuticals, Llc |
Pancreatic polypeptide family motifs and polypeptides comprising the same
|
DE602005023592D1
(de)
*
|
2004-03-09 |
2010-10-28 |
Absorber Ab |
Endothelvorläuferzellen und verfahren zur verwendung davon
|
EP2075254A1
(de)
|
2004-03-30 |
2009-07-01 |
NsGene A/S |
Therapeutische Verwendung des Wachstumsfaktors NsG33
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
PT1786454E
(pt)
*
|
2004-08-19 |
2010-08-18 |
Biogen Idec Inc |
Variantes de neublastina
|
CN101123978B
(zh)
|
2004-08-19 |
2012-12-12 |
比奥根艾迪克Ma公司 |
神经胚素变体
|
JP2008526762A
(ja)
|
2004-12-30 |
2008-07-24 |
プライムジェン バイオテック エルエルシー |
組織再生および創傷治癒のための脂肪由来幹細胞
|
MX2007009173A
(es)
*
|
2005-01-31 |
2008-03-10 |
Cognate Therapeutics Inc |
Celulas estromaticas de adulto derivadas de adiposo que exhiben caracteristicas de celulas endoteliales.
|
CN103361303B
(zh)
|
2005-03-31 |
2015-09-30 |
斯丹姆涅恩有限公司 |
制备一种高度纯化来自羊膜的细胞群的方法
|
US8088567B2
(en)
*
|
2005-04-01 |
2012-01-03 |
Nsgene A/S |
Human immortalised neural precursor cell line
|
WO2006117212A2
(en)
|
2005-05-04 |
2006-11-09 |
Develogen Aktiengesellschaft |
Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
|
WO2006122550A2
(en)
*
|
2005-05-17 |
2006-11-23 |
Nsgene A/S |
Storage container comprising an implantable therapy system
|
MX348154B
(es)
|
2005-06-21 |
2017-05-30 |
Xoma (Us) Llc |
Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
|
TW200726474A
(en)
*
|
2005-07-15 |
2007-07-16 |
Cognate Therapeutics Inc |
The immunophenotype and immunogenicity of human adipose derived cells
|
US8357666B2
(en)
*
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
AU2006308312A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Nsgene A/S |
Implantable Biocompatible Immunoisolatory Vehicle for Delivery of GDNF
|
CA2633468C
(en)
|
2005-12-14 |
2014-02-18 |
Licentia Ltd |
Novel neurotrophic factor protein and uses thereof
|
AU2006332971B2
(en)
*
|
2005-12-30 |
2013-03-07 |
Neurotech Usa, Inc. |
Micronized device for the delivery of biologically active molecules and methods of use thereof
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP1993590B1
(de)
*
|
2006-03-01 |
2013-12-25 |
Biogen Idec MA Inc. |
Zusammensetzungen und verfahren zur verabreichung von proteinen der gdnf-liganden-familie
|
WO2008011006A2
(en)
|
2006-07-18 |
2008-01-24 |
University Of Utah Research Foundation |
Methods for treating pain and screening analgesic compounds
|
WO2008088738A2
(en)
|
2007-01-17 |
2008-07-24 |
Stemnion, Inc. |
Novel methods for modulating inflammatory and/or immune responses
|
CA2682578C
(en)
|
2007-04-03 |
2015-05-26 |
Oxyrane Uk Limited |
Glycosylation of molecules
|
TWI445544B
(zh)
|
2007-05-01 |
2014-07-21 |
Biogen Idec Inc |
增進血管形成之組合物及方法
|
US20110135648A1
(en)
*
|
2007-08-08 |
2011-06-09 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
FI20070808A0
(fi)
|
2007-10-25 |
2007-10-25 |
Mart Saarma |
GDNF:n silmukointivariantit ja niiden käytöt
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
AU2009233845A1
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
WO2009152084A2
(en)
|
2008-06-11 |
2009-12-17 |
Cell4Vet Llc |
Adipose tissue-derived stem cells for veterinary use
|
SG195542A1
(en)
|
2008-10-10 |
2013-12-30 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
CN102282254B
(zh)
*
|
2008-11-14 |
2015-12-16 |
维赛特公司 |
源于人多能干细胞的胰腺细胞的包封
|
EP2379711B8
(de)
|
2008-12-23 |
2017-03-22 |
BOCO Silicon Valley, Inc. |
Zielpopulationen von oligodendrozyten-vorläuferzellen und verfahren zur herstellung und verwendung davon
|
AU2010206374B2
(en)
|
2009-01-23 |
2013-01-17 |
Gloriana Therapeutics Sarl |
Improved cell lines and their use in encapsulated cell biodelivery
|
EP2389191A2
(de)
|
2009-01-23 |
2011-11-30 |
NsGene A/S |
Expression von neuropeptiden in säugetierzellen
|
EP2230248A1
(de)
|
2009-03-03 |
2010-09-22 |
Assistance Publique - Hôpitaux de Paris |
Verfahren zur Erhöhung des Pools von NGN3+-endokrinen Vorläuferzellen und Zellmasse der endokrinen Pankreas
|
US9511093B2
(en)
*
|
2009-03-23 |
2016-12-06 |
The Texas A & M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
EP2421981B1
(de)
*
|
2009-04-23 |
2013-08-14 |
Neurotech USA, Inc. |
Zelllinien zur produktion von prostaglandin-f2-alpha (pgf2a) und verwendungen davon
|
AR076541A1
(es)
|
2009-05-05 |
2011-06-22 |
Amgen Inc |
Mutantes de fgf21 y usos del mismo
|
CA2760674A1
(en)
|
2009-05-05 |
2010-11-11 |
Amgen Inc. |
Fgf21 mutants and uses thereof
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
CN104651428A
(zh)
|
2009-09-29 |
2015-05-27 |
根特大学 |
水解甘露糖-1-磷酸-6-甘露糖连接为磷酸-6-甘露糖
|
EP2486128A4
(de)
*
|
2009-10-08 |
2013-10-09 |
Neurotech Usa Inc |
Verwendung von pedf in einem eingekapselten ausgabesystem auf zellbasis
|
JP2013511272A
(ja)
|
2009-11-19 |
2013-04-04 |
オキシレイン ユーケー リミテッド |
哺乳類様複合n−グリカンを生成する酵母株
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
AR081743A1
(es)
|
2010-03-26 |
2012-10-17 |
Philip Morris Prod |
Fabricacion de capsulas de nucleo/caparazon de diferentes geometrias y tratamiento a partir de las mismas
|
EP2558497A2
(de)
|
2010-04-15 |
2013-02-20 |
Amgen Inc. |
Menschlicher fgf-rezeptor und beta-klotho-bindeproteine
|
JP5988961B2
(ja)
|
2010-04-28 |
2016-09-07 |
ザ ジェイ. デヴィッド グラッドストーン インスティテューツ |
心筋細胞を発生させるための方法
|
EP3399026A1
(de)
|
2010-06-14 |
2018-11-07 |
The Scripps Research Institute |
Neuprogrammierung von zellen für ein neues zellschicksal
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
WO2012042386A2
(en)
|
2010-09-29 |
2012-04-05 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
WO2012042387A2
(en)
|
2010-09-29 |
2012-04-05 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated n-glycans
|
WO2012041328A1
(en)
|
2010-10-01 |
2012-04-05 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
EP2625264B1
(de)
|
2010-10-08 |
2022-12-07 |
Terumo BCT, Inc. |
Verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem mit steuerungsbedingungen
|
WO2012075184A2
(en)
|
2010-12-02 |
2012-06-07 |
Neurotech Usa, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
WO2012084999A1
(en)
|
2010-12-21 |
2012-06-28 |
Universite De Strasbourg |
Prokineticin 1 receptor agonists and their uses
|
EP2468280A1
(de)
|
2010-12-21 |
2012-06-27 |
Université de Strasbourg |
Verwendung von Prokineticin-1-Rezeptoragonisten zur Unterstützung der Differenzierung von Epicardin und Vorläuferzellen
|
JP2014513948A
(ja)
|
2011-04-20 |
2014-06-19 |
ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション |
β2ミクログロブリン欠損細胞
|
RU2637085C2
(ru)
|
2011-06-06 |
2017-11-29 |
КИНЕТА УАН, ЭлЭлСи |
Фармацевтические композиции на основе shk и способы их получения и использования
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
BR112014022624A2
(pt)
|
2012-03-15 |
2017-07-11 |
Oxyrane Uk Ltd |
métodos e materiais para tratamento de doença de pompe
|
HUE063231T2
(hu)
|
2012-04-17 |
2024-01-28 |
Univ Washington Through Its Center For Commercialization |
II. osztályú HLA-hiányos sejtek, II. osztályú HLA fehérjéket expresszálni képes I. osztályú HLA-hiányos sejtek és alkalmazásuk
|
US20150150796A1
(en)
|
2012-05-30 |
2015-06-04 |
Neurotech Usa, Inc. |
Cryopreserved Implantable Cell Culture Devices and Uses Thereof
|
US9402710B2
(en)
*
|
2012-07-16 |
2016-08-02 |
The Board Of Trustees For The Leland Stanford Junior University |
Macroporous 3-D scaffolds for tissue engineering
|
CN104936603A
(zh)
|
2012-08-01 |
2015-09-23 |
联合治疗公司 |
利用前列环素处理的内皮祖细胞的肺动脉高血压的治疗
|
CN111803523A
(zh)
|
2012-08-01 |
2020-10-23 |
联合治疗公司 |
利用间充质干细胞的肺动脉高血压的治疗
|
ES2697573T3
(es)
|
2013-01-09 |
2019-01-25 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
WO2014136065A2
(en)
|
2013-03-05 |
2014-09-12 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
3次元大収容力細胞封入デバイスアセンブリー
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
CN105377286B
(zh)
|
2013-05-31 |
2021-07-02 |
犹他大学研究基金会 |
芋螺毒素(conotoxin)肽,其医药组合物和用途
|
CA2922483A1
(en)
|
2013-09-11 |
2015-03-19 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
WO2015042580A1
(en)
|
2013-09-23 |
2015-03-26 |
Biogen Idec Ma Inc. |
Compositions and methods for treatment of neuropathic pain
|
US20160090569A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled Feed
|
CA2968211C
(en)
|
2014-11-20 |
2024-01-09 |
Viacyte, Inc. |
Instruments and methods for loading cells into implantable devices
|
ES2833457T3
(es)
|
2015-05-27 |
2021-06-15 |
Neurotech Usa Inc |
Uso de terapia con células encapsuladas para el tratamiento del glaucoma
|
US20160361380A1
(en)
|
2015-06-12 |
2016-12-15 |
Nymox Corporation |
Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
|
EP3464565A4
(de)
|
2016-05-25 |
2020-01-01 |
Terumo BCT, Inc. |
Zellexpansion
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
EP3272877A1
(de)
|
2016-07-18 |
2018-01-24 |
ETH Zurich |
B-zell-mimetische zellen
|
SG11201811763SA
(en)
|
2016-07-18 |
2019-02-27 |
Eth Zuerich |
B-cell-mimetic cells
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
KR102606101B1
(ko)
|
2016-10-24 |
2023-11-27 |
유나이티드 쎄러퓨틱스 코포레이션 |
트레프로스티닐에 의한 msc 면역조절 특성의 향상
|
CA3042495A1
(en)
|
2016-11-10 |
2018-05-17 |
Viacyte, Inc. |
Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
|
US11629332B2
(en)
|
2017-03-31 |
2023-04-18 |
Terumo Bct, Inc. |
Cell expansion
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
GB2569266A
(en)
*
|
2017-10-13 |
2019-06-19 |
Nottingham Univ Hospitals Nhs Trust |
Methods of forming solid or liquid charged capsules
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
WO2023164171A2
(en)
|
2022-02-25 |
2023-08-31 |
Viacyte, Inc. |
Multilayer implantable cell encapsulation devices and methods thereof
|